KLK3 and metastatic neoplasm: PSA is still regarded as a highly specific marker of prostatic origin, but due to its decreased or even lost expression in higher grade or metastatic tumors, which was already noted in initial studies, its sensitivity is clearly limited, which necessitates the use of additional markers in PSA negative cases [5].